Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InMed Pharmaceuticals (INM) Non Operating Income (2023 - 2024)

Historic Non Operating Income for InMed Pharmaceuticals (INM) over the last 2 years, with Q2 2024 value amounting to $103421.0.

  • InMed Pharmaceuticals' Non Operating Income fell 3028.91% to $103421.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $528803.0, marking a year-over-year change of. This contributed to the annual value of $527901.0 for FY2024, which is 720.11% up from last year.
  • As of Q2 2024, InMed Pharmaceuticals' Non Operating Income stood at $103421.0, which was down 3028.91% from $121458.0 recorded in Q1 2024.
  • Over the past 5 years, InMed Pharmaceuticals' Non Operating Income peaked at $155567.0 during Q1 2023, and registered a low of $103421.0 during Q2 2024.